Medications for Attention Deficit Disorder With Hyperactivity

27 results
  • amphetamine sulfate

    (Amphetamine Sulfate)
    Granules Pharmaceuticals Inc.
    Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity in conjunction with a comprehensive treatment program, and as a short-term adjunct for exogenous obesity in patients not responding to other weight loss strategies.
  • amphetamine sulfate

    (amphetamine sulfate)
    Lannett Company, Inc.
    Amphetamine sulfate tablets (5 mg and 10 mg) are indicated for narcolepsy, Attention Deficit-Disorder with Hyperactivity as part of a comprehensive treatment program, and short-term management of exogenous obesity as an adjunct to a caloric restriction regimen in patients unresponsive to other therapies.
  • atomoxetine hydrochloride

    (atomoxetine hydrochloride)
    Apotex Corp.
    Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric and adult patients. It should be part of a comprehensive treatment program that may include psychological, educational, and social interventions, and is not suitable for those with symptoms due to environmental factors or other psychiatric disorders.
  • chlorpromazine hydrochloride

    (chlorpromazine hydrochloride)
    Camber Pharmaceuticals, Inc.
    This drug is indicated for treating schizophrenia, controlling nausea and vomiting, and relieving restlessness before surgery. It also addresses acute intermittent porphyria, aids in tetanus treatment, manages mania, treats intractable hiccups, and handles severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.
  • clonidine hydrochloride

    (Clonidine Hydrochloride)
    Somerset Therapeutics, LLC
    Clonidine hydrochloride extended-release tablets are indicated for treating attention deficit hyperactivity disorder (ADHD), both as a standalone treatment and as an adjunct to stimulant medications.
  • dexedrine

    (dextroamphetamine sulfate)
    Amneal Pharmaceuticals LLC
    DEXEDRINE is indicated for the treatment of narcolepsy and Attention Deficit Disorder with Hyperactivity (ADHD) in children aged 6 to 16 years, as part of a comprehensive treatment program that may include psychological and educational interventions. It is not intended for symptoms caused by environmental factors or primary psychiatric disorders.
  • dexmethylphenidate hydrochloride

    (Dexmethylphenidate hydrochloride)
    Amneal Pharmaceuticals of New York LLC
    Dexmethylphenidate hydrochloride extended-release capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older, as part of a comprehensive treatment program. Its long-term effectiveness has not been systematically evaluated beyond 7 weeks.
  • dexmethylphenidate hydrochloride

    (dexmethylphenidate hydrochloride)
    Tris Pharma Inc
    Dexmethylphenidate hydrochloride tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).